A Phase III Randomized Trial of Gemcitabine Cisplatin and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed Advanced Biliary Tract Cancers

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Advanced Biliary Tract Cancers
  • Age: Between 18 - 100 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1) Histologically/cytologically confirmed intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, or gallbladder cancer 2) Documented metastatic or locally advanced unresectable disease on CT or MR imaging within 28 days prior to registration

You may not be eligible for this study if the following are true:

  • 1) Patients with a current diagnosis of ampullary cancer 2) Patients that have been treated with adjuvant therapy within 6 months prior to registration 3) Patients with a history of peripheral neuropathy

If you are registered as a volunteer, please login to the dashboard to send referrals.